SAN DIEGO (BUSINESS WIRE) Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host its Investor and Analyst Day on Tuesday, December 12, 2023.Members of Ligand’s senior management team will provide an update on the company’s strategy and portfolio as well as a multi-year financial outlook and a 2024 guidance p.
Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023.
Members of Ligand’s senior management team will provide an update on the company’s.
Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023.
Members of Ligand's senior management team will provide an update on the company's strategy and portfolio as well as a multi-year financial.
Palvella Therapeutics and Ligand Pharmaceuticals (LGND) Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.